MedTrace Logo

Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)

NCT00724243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2015-09-04

Study results available
· View outcomes & findings →

Summary

This study will gather information on the safety and efficacy of patients with rheumatoid arthritis (RA) who are starting treatment with infliximab for the first time. Patients will be treated in the usual manner according to local guidelines and normal clinical practice.

Conditions

Interventions

DRUG

Infliximab

Infliximab given in accordance with the local summary of product characteristics

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-10-31
Completion
2008-10-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00724243 on ClinicalTrials.gov